The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Speakers' Bureau - Bristol-Myers Squibb; Merck; MSD Oncology; Ono Pharmaceutical; Takeda
Prognostic impact of first-line (1L) chemotherapy cycles in patients with metastatic urothelial carcinoma receiving avelumab 1L maintenance.
 
Satoshi Katayama
No Relationships to Disclose
 
Tatsuhi Kawada
No Relationships to Disclose
 
Keita Kobayashi
Speakers' Bureau - Bayer; Bayer; MSD; Nippon Kayaku
 
Ryuta Watanabe
No Relationships to Disclose
 
Yoichiro Tohi
No Relationships to Disclose
 
Shinkuro Yamamoto
No Relationships to Disclose
 
Atsushi Takamoto
No Relationships to Disclose
 
Ryutaro Shimizu
No Relationships to Disclose
 
Kei Daizumoto
No Relationships to Disclose
 
Taichi Nagami
No Relationships to Disclose
 
Koichiro Wada
No Relationships to Disclose
 
Junya Furukawa
No Relationships to Disclose
 
Noriyoshi Miura
No Relationships to Disclose
 
Shuichi Morizane
No Relationships to Disclose
 
Keiji Inoue
Speakers' Bureau - Merck
 
Mikio Sugimoto
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb Japan; Janssen; Nippon Shinyaku; Novartis; Pfizer; Takeda
 
Koji Shiraishi
No Relationships to Disclose
 
Motoo Araki
No Relationships to Disclose